- Home
- INSP vs SRPT Comparison
INSP vs SRPT Comparison
Compare INSP & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSP | SRPT |
|---|---|---|
| Founded | 2007 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | INSP | SRPT |
|---|---|---|
| Price | $59.81 | $17.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 28 |
| Target Price | ★ $101.07 | $25.56 |
| AVG Volume (30 Days) | 1.4M | ★ 2.0M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 179.43 | N/A |
| EPS | ★ 4.89 | N/A |
| Revenue | $82,050,000.00 | ★ $2,198,237,000.00 |
| Revenue This Year | $8.44 | N/A |
| Revenue Next Year | $8.60 | N/A |
| P/E Ratio | $12.25 | ★ N/A |
| Revenue Growth | ★ 62.18 | 15.58 |
| 52 Week Low | $53.11 | $10.42 |
| 52 Week High | $172.95 | $103.32 |
Technical Indicators
Market Signals| Indicator | INSP | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 36.23 | 45.50 |
| Support Level | $57.57 | $17.05 |
| Resistance Level | $84.26 | $19.55 |
| Average True Range (ATR) | 4.10 | 0.82 |
| MACD | 0.85 | 0.14 |
| Stochastic Oscillator | 7.32 | 52.48 |
Price Performance
Historical ComparisonAbout INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.